The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.
An Unfiltered Account of the October 7th Attack on Israel and the War on Gaza." On the morning of Oct. 7, 2023 the militant group known as Hamas launched a vicious attack on Israel in the most recent ...